DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Pivot X, Gligorov J, Müller V et al.
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study.

Lancet Oncol 2013;
14: 962-970

Download Bibliographical Data

Search in:
Access: